You are here

  • Home
  • Archive
  • Volume 74, Issue 3
  • A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C

Article info

Article menu
Download PDFPDF
Letters
A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C

Authors

  • Yi-Ming Chen Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan Faculty of Medicine, National Yang Ming University, Taipei, Taiwan Institute of Biomedical Science, National Chung Hsing University, Taichung, Taiwan Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Hsin-Hua Chen Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan Faculty of Medicine, National Yang Ming University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Yi-Hsing Chen Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan Faculty of Medicine, National Yang Ming University, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Tsu-Yi Hsieh Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Chia-Wei Hsieh Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan Institute of Biomedical Science, National Chung Hsing University, Taichung, Taiwan Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Wei-Ting Hung Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Joung-Liang Lan Division of Immunology and Rheumatology, China Medical University Hospital, Taichung, Taiwan College of Medicine, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Der-Yuan Chen Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan Faculty of Medicine, National Yang Ming University, Taipei, Taiwan Institute of Biomedical Science, National Chung Hsing University, Taichung, Taiwan Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan Institute of Microbiology and Immunology, Chung Shan Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Der-Yuan Chen, Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan; No. 1650, Sec. 4, Taiwan Boulevard, Taichung 40705, Taiwan; dychen{at}vghtc.gov.tw
View Full Text

Citation

Chen Y, Chen H, Chen Y, et al
A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C
Annals of the Rheumatic Diseases 2015;74:626-627.

Publication history

  • First published December 1, 2014.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions